Pulike Biological Engineering Inc
SSE:603566
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
10.95
24.1
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Pulike Biological Engineering Inc
Other Receivables
Pulike Biological Engineering Inc
Other Receivables Peer Comparison
Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Pulike Biological Engineering Inc
SSE:603566
|
Other Receivables
ÂĄ73.2m
|
CAGR 3-Years
67%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Other Receivables
ÂĄ111m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Other Receivables
ÂĄ297.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
26%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Other Receivables
ÂĄ1.3B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Other Receivables
ÂĄ3.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
0%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Other Receivables
ÂĄ74.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Pulike Biological Engineering Inc's Other Receivables?
Other Receivables
73.2m
CNY
Based on the financial report for Jun 30, 2024, Pulike Biological Engineering Inc's Other Receivables amounts to 73.2m CNY.
What is Pulike Biological Engineering Inc's Other Receivables growth rate?
Other Receivables CAGR 5Y
54%
Over the last year, the Other Receivables growth was -23%. The average annual Other Receivables growth rates for Pulike Biological Engineering Inc have been 67% over the past three years , 54% over the past five years .